{"title":"[血清对糖尿病患者脑功能的影响]。","authors":"A S Efimov, B N Man'kovskiĭ","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The vasoactive drug sermion was used for the treatment of patients suffering of diabetes mellitus with clinical manifestations of central neuropathy. A course of sermion treatment effected positively the clinical course of neuropathy also confirmed electroencephalographically and by the parameters of visual and somatosensory evoked potentials of the brain. Results indicate the possibility of using sermion in the treatment of brain affections in patients with diabetes mellitus.</p>","PeriodicalId":23717,"journal":{"name":"Vrachebnoe delo","volume":" 11","pages":"73-6"},"PeriodicalIF":0.0000,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The effect of sermion on brain function in diabetics].\",\"authors\":\"A S Efimov, B N Man'kovskiĭ\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The vasoactive drug sermion was used for the treatment of patients suffering of diabetes mellitus with clinical manifestations of central neuropathy. A course of sermion treatment effected positively the clinical course of neuropathy also confirmed electroencephalographically and by the parameters of visual and somatosensory evoked potentials of the brain. Results indicate the possibility of using sermion in the treatment of brain affections in patients with diabetes mellitus.</p>\",\"PeriodicalId\":23717,\"journal\":{\"name\":\"Vrachebnoe delo\",\"volume\":\" 11\",\"pages\":\"73-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vrachebnoe delo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vrachebnoe delo","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[The effect of sermion on brain function in diabetics].
The vasoactive drug sermion was used for the treatment of patients suffering of diabetes mellitus with clinical manifestations of central neuropathy. A course of sermion treatment effected positively the clinical course of neuropathy also confirmed electroencephalographically and by the parameters of visual and somatosensory evoked potentials of the brain. Results indicate the possibility of using sermion in the treatment of brain affections in patients with diabetes mellitus.